Scilex Holding (SCLX) Non Operating Income (2022 - 2026)

Scilex Holding (SCLX) posted quarterly Non Operating Income of -$13.5 million for Q1 2026, down 841.53% year-over-year from $1.8 million in Q1 2025, and down 120.74% on a QoQ basis from $65.0 million in Q4 2025.

Scilex Holding (SCLX) Non Operating Income (2022 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Non Operating Income for 5 consecutive years, with -$13.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Non Operating Income fell 841.53% year-over-year to -$13.5 million; the TTM figure through Mar 2026 stood at -$43.3 million (down 350.33% YoY), while the FY2025 annual figure was -$28.0 million, down 364.64% from the prior year.
  • Non Operating Income came in at -$13.5 million for Q1 2026 at Scilex Holding, down from $65.0 million in the prior quarter.
  • The five-year high for Non Operating Income was $65.0 million in Q4 2025, with the low at -$71.3 million in Q3 2025.
  • Average Non Operating Income over 5 years is -$538882.4, with a median of -$3.1 million recorded in 2023.
  • Across the five-year window, Non Operating Income surged 817.88% in 2024 and slumped 841.53% in 2026, its largest moves.
  • Year by year, Non Operating Income stood at $1.9 million in 2022, then slumped by 260.94% to -$3.1 million in 2023, then soared by 817.88% to $21.9 million in 2024, then surged by 196.53% to $65.0 million in 2025, then slumped by 120.74% to -$13.5 million in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods registered -$13.5 million, $65.0 million, and -$71.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -65.00 Mn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -294.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -2.31 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.49 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -138.00 Mn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 235.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -861.00 Mn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -13.48 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.48 Mn
Dec 31, 2025 64.99 Mn
Sep 30, 2025 -71.31 Mn
Jun 30, 2025 -23.52 Mn
Mar 31, 2025 1.82 Mn
Dec 31, 2024 21.92 Mn
Sep 30, 2024 15.53 Mn
Jun 30, 2024 -21.96 Mn
Mar 31, 2024 -4.90 Mn
Dec 31, 2023 -3.05 Mn
Sep 30, 2023 3.28 Mn
Jun 30, 2023 -3.84 Mn
Mar 31, 2023 -5.27 Mn
Dec 31, 2022 1.90 Mn
Sep 30, 2022 32.11 Mn
Jun 30, 2022 -6.40 Mn
Mar 31, 2022 3.03 Mn